Overview

• ECDC’s fourth survey, released Sept. 11, confirms fast hospital transmission of the drug‑resistant yeast C. auris, which can persist on surfaces and equipment.
• EU/EEA countries logged more than 4,000 cases from 2013–2023, including a record 1,346 cases in 2023 reported by 18 countries.
• Recent outbreaks were identified in Cyprus, France and Germany, while Greece, Italy, Romania and Spain report such widespread transmission that individual outbreaks can no longer be distinguished.
• Only 17 of 36 surveyed countries have national surveillance and just 15 have dedicated infection‑prevention guidance, and the agency says the true scale is likely under‑reported.
• ECDC officials urge early detection, patient isolation and rigorous disinfection to curb spread, as Bloomberg-cited data show no new antifungal funding commitments in 2025 after a 2022 surge.